Is Mounjaro FDA-Approved For Weight Loss?
This treatment for type 2 diabetes is now FDA-approved for weight loss too. Read on to discover what it can do for you and how to get it at Levity.
46 lbs
Average weight lost in a year using Mounjaro.
300%
More effective than diet and exercise alone.
100,000+
People have lost weight using injectable GLP-1s.
Take our online consultation. Based on your answers, we'll recommend you the right medication.
Send us recent blood test results. From within 6 months. Or, quickly book a new test and send us that.
We review and issue your prescription. It's all included in the cost of our program.
Get your medication and start treatment. Your full membership starts. We're here with all the ongoing support you’ll need on your weight loss journey.
How's your progress and how have you been feeling?
My weight today is 204 lbs and I'm feeling good!
Great progress so far! Based on your results, I'm happy for you to continue with your Ozempic prescription.
Our US-based clinical team is always on hand to help. We track your weight with you online to ensure your treatment is working as expected. If at any point you need to talk to us we're available 9AM to 5PM EST Monday to Friday.
Get started today →Based on several clinical studies, GLP-1 medications can help you to lose 5–20% of your body weight in a year.
In clinical trials of Wegovy in non-diabetic people, the average weight loss was 15% over one year. In another Wegovy trial involving people with diabetes, the average weight loss was 9.6%. These findings suggest that people with diabetes may experience slightly less weight loss on these medications compared to those without. Non-diabetic patients who used Saxenda for 56 weeks, on average, lost 9% of their body weight.
The Ozempic trials exclusively included people with diabetes, and they achieved an average weight loss of 7% over one year.
It's important to remember that the participants in these studies combined medication with diet and exercise.
Our program offers GLP-1 injectable treatments, which are proven to be effective for sustainable weight loss.
GLP-1s are natural gut hormones that signal your brain to reduce appetite, enhance metabolism and improve digestion, which causes prolonged fullness and better nutrient absorption. The GLP-1 medications we offer are: Semaglutide/Glycine/B12, Ozempic®, Wegovy®, Saxenda®, and Mounjaro™.
All our medications are clinically validated and can support your weight loss journey. Your Levity clinical reviewer will determine the most suitable option for you.
We combine our prescription cost with the medication and service benefits into one total monthly cost. This varies based on the medication you choose from the treatments you’re eligible for. Typically, the total cost ranges from $225–$1,599 a month.
We don't currently accept insurance, but we’re planning to in the future.
If you don’t feel you’re getting the results you want from your weight loss medication, there are steps you can take.
First, it's important to give the medication some time to work. Our experts recommend using your weight loss medication for at least 6 months to judge its effectiveness. Remember that individual responses can vary, and your body may need some time to adapt. We also start your treatment at a low dose and increase it gradually, so it’s normal to not see a lot of weight loss in the first month or two.
We’re here to support you throughout your weight loss journey. If you have concerns about the effectiveness of your medication, or any side effects you’re experiencing, your Levity medical team is ready to support you. They can provide guidance, answer your questions and explore possible adjustments to your treatment plan.
Remember, you also have the flexibility to cancel your treatment at any time. We understand that weight loss is a unique and evolving process, and your health and satisfaction are our top priorities. If, after consultation and a reasonable trial period, you and your medical team decide that the medication is not the right fit for you, you have the freedom to explore alternative options.
Our medications belong to a class of drugs known as GLP-1s, which are clinically tested, stimulant-free, and non-habit forming. Their most common side effects are gastrointestinal discomfort (nausea, vomiting, diarrhea), potential episodes of hypoglycemia (low blood sugar), reactions at the injection site, reduced appetite. These typically resolve over the first few weeks of treatment.
In the most recent clinical trials, less than 5% of people discontinued GLP-1 medications because of side effects. If you do experience any side effects, you can reach out to our clinical team directly for support.
If you miss a dose, it should be taken as soon as possible.
If you miss a dose for more than five days, please contact us at care@joinlevity.com for further advice.
The cost of medication, prescription, clinical consultation and shipping are all included in one monthly fee. This cost varies based on the medication you’re prescribed. It also includes follow-up appointments, coaching and any additional medication you may be offered to help reduce side effects.
We supply 26 states: Colorado, Florida, Georgia, Hawaii, Illinois, Iowa, Maine, Maryland, Massachusetts, Mississippi, Missouri, Montana, Nebraska, Nevada, New York, North Dakota, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Virginia, Washington, Wyoming.
We hope to add more locations soon, so if you’re interested in our treatments, please contact us at care@joinlevity.com and we’ll do our best to reach you as soon as possible.
Head of Pharmacy | PharmD
License: PS56867
Board Certified Family Physician | MD
NPI: 1639311509
This treatment for type 2 diabetes is now FDA-approved for weight loss too. Read on to discover what it can do for you and how to get it at Levity.
Explore how individuals using weight-loss medication overcome judgment and embrace progress, finding confidence along the way.
Take a deep dive into three of the most popular GLP-1 weight loss treatments with insights from expert clinicians.